PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
13-Mar-2025 Merck Announces Positive Data from Phase 3 Trials that Show the Investigational, Once-Daily, Oral, Two-Drug Regimen of Doravirine/Islatravir (DOR/ISL) Maintained HIV-1 Viral Suppression at Week 48 Merck
12-Mar-2025 Arvinas and Pfizer Announce Positive Topline Results from Phase 3 VERITAC-2 Clinical Trial Pfizer
11-Mar-2025 Modus Therapeutics Announces Completion of Patient Enrollment in the SEVUSMART Phase I Study for Severe Malaria Modus Therapeutics
11-Mar-2025 Novo Nordisk A/S: CagriSema demonstrates superior weight loss in adults with obesity or overweight and type 2 diabetes in the REDEFINE 2 trial Novo Nordisk
10-Mar-2025 SMART Trial two-year data continues to demonstrate superior valve performance for Evolut TAVR™ system in small annulus patients Medtronic
04-Mar-2025 Mural Health and ICON Announce Partnership to Enhance Participant and Site Experience in Clinical Trials Mural Health
03-Mar-2025 Coronado Research Announce the Appointment of Stephen Ralston as EVP Market Access and HEOR Coronado Research
03-Mar-2025 New Bonus Modules for the Certificate GMP Training Pharma Lessons
26-Feb-2025 Clinion’s Latest Innovation at ACDM25 - Be the First to Experience Agentic AI Clinion
25-Feb-2025 Introducing our New ICH E6 R3 Good Clinical Practice Training Course PharmaEduCenter
21-Feb-2025 PharmaBlock Launches Commercial GMP Workshop 503 at Zhejiang Site PharmaBlock
20-Feb-2025 CROPrime Offers Biotech and Pharma Tailored Solutions for Clinical Trials in the UK CROPrime
19-Feb-2025 Raising Awareness About Clinical Trials: Why It Matters CROPrime
18-Feb-2025 CluePoints named as Finalist in 2025 ACDM Awards CluePoints
14-Feb-2025 Combined health and economic data could help thousands of children at risk of respiratory illnesses Graphnet Health
13-Feb-2025 Phastar Secures SCOPE US ‘Best in Show’ Accolade for Clinical Intelligence Platform Phastar
10-Feb-2025 Boehringer’s nerandomilast meets primary endpoint in Phase III study FIBRONEER™-ILD, in progressive pulmonary fibrosis Boehringer Ingelheim
06-Feb-2025 Palobiofarma Partners with Flex Databases for Advanced Pharmacovigilance Management Flex Databases s.r.o.
31-Jan-2025 Merck Announces Decision to Stop Phase 3 HYPERION Trial Evaluating WINREVAIR™ (sotatercept-csrk) Early and Move to Final Analysis Merck
28-Jan-2025 Upperton completes build of new £7m sterile manufacturing facility. Upperton Pharma Solutions